Novo Nordisk faces formidable challenges from Eli Lilly and new rivals, but its first-mover advantage and expanded manufacturing capacity remain strong. Read more on NVO stock here.

Professor Arne Astrup is also involved in project to change widely-accepted definition of ultra-processed food ...

European stocks look like newly good investments amid Trump's tariff war and US economic unpredictabilities. European defense stocks are particularly appealing.

Denmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the ...

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...

European shares experienced gains driven mainly by healthcare stocks, despite fears of an escalating U.S.-EU trade war. The ...

Professor Julia Vorholt's work has changed how we think about plant health. Her innovative research on plant microbiomes holds the potential to transform agriculture. For her achievements, the ...

European markets are expected to open in mixed territory Thursday, stumbling lower as President Donald Trump’s tariffs policy upends global trading relations.

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

U.S. equities were mixed at midday as the markets weighed a better-than-expected report on inflation and more tariff news.

Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to Zealand Pharma in a licensing and development agreement. Zealand Pharma's ...

WASHINGTON (Reuters) -President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and pharmaceutical companies that could benefit from his policy ...